Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Lactobacillus reuteri NCIMB 30242 and Improved Blood Lipid Profile

Research synthesisLow evidenceSmall effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects of Lactobacillus reuteri NCIMB 30242 on blood lipid profiles, but only one was a randomized controlled trial showing a small effect size with statistically significant reductions in LDL-C/HDL-C ratio and apoB-100/apoA-1 ratio. The most studied population is hypercholesterolemic adults, and no consistent dose range was reported. The evidence base is too small to draw firm conclusions.

  • Studied populations: hypercholesterolemic adults

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Only one of the three studies reported statistically significant findings, and it was a single RCT with a small effect size. No consistent dose or form information is available. The two reviews are not original research and may overstate the effect.

Generated Jun 11, 2026
3 of 3 papers
Back to top